- Narrative review of 20 experimental studies (nine in vitro, one ex vivo, ten in vivo) on lipid emulsions for local anesthetic systemic toxicity, searched 1998 to 2026.
- Compares 100% long-chain triglyceride emulsions with 50/50 medium/long-chain mixtures, and 20% versus 30% lipid concentration.
- Authors report 100% LCT emulsions gave greater overall cardiovascular recovery, mainly through lipid-shuttle and myocardial effects, while 50% MCT/LCT showed stronger vascular effects.
- Concentration evidence came only from 100% LCT products and generally favored 30% over 20% when given at the same volume; the authors call the findings hypothesis-generating.
Regional
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
- This is a narrative review of stellate ganglion block in contemporary anesthesia practice, so it reports no pooled sample size or primary outcome data.
- It covers ultrasound-guided technique, dose-finding work on local anesthetic volume and concentration, and continuous blockade in selected refractory conditions.
- Reported uses span pain (complex regional pain syndrome, herpes zoster), non-pain indications (PTSD, ventricular arrhythmias, vasomotor symptoms), and perioperative analgesia and inflammation modulation.
- The authors conclude that multicenter prospective studies and standardized procedural parameters are needed before SGB is used on a broader evidence-based basis.
AI summary not available. Read the source abstract on PubMed.
- Systematic review and meta-analysis of five randomized trials, totaling 1613 adults aged 60 or older having surgery under regional anesthesia.
- Compared intraoperative dexmedetomidine with propofol, with delirium assessed using CAM or CAM-ICU.
- Delirium occurred in 7.7% of dexmedetomidine patients versus 16.7% with propofol (RR 0.48, 95% CI 0.36-0.64; P < .001), with low heterogeneity (I² = 13.4%).
- The authors conclude dexmedetomidine is associated with less postoperative delirium, and they rated the certainty of evidence as moderate by GRADE.
- This systematic review with narrative synthesis (no meta-analysis) included 28 preclinical studies: 12 animal or animal ex vivo and 16 human cadaver studies.
- It compared injection pressure and pressure-time patterns across needle-tip locations: intraneural, intrafascicular, perineural, and extraneural.
- Intraneural injection generally produced higher peak and plateau pressures than perineural, but overlap across locations was substantial, and low pressure did not reliably exclude intraneural placement.
- The authors conclude pressure monitoring gives only a nonspecific warning, with no validated threshold or injection rate and no evidence yet that it reduces nerve injury.
- Systematic review and meta-analysis of 8 randomized controlled trials including 543 adults, comparing short-term peripheral nerve stimulation with sham or usual care.
- The primary outcome was change in average pain intensity during the implantation period.
- Average pain fell during implantation at 1-4 weeks (SMD -0.48, 95% CI -0.71 to -0.26) and 5-8 weeks (SMD -0.96, 95% CI -1.22 to -0.70), but not after electrode removal.
- The authors describe the evidence as preliminary: pain relief occurs during implantation, but not all outcomes show benefit that persists after removal.
- Systematic review and Bayesian meta-analysis of 14 randomised trials (903 adults) of regional analgesia after kidney transplantation.
- Only quadratus lumborum and transversus abdominis plane blocks could be pooled against control, and both lowered pain at every pooled time point.
- At 24 hours, QL and TAP blocks reduced opioid consumption by 15.5 and 10.5 MME (95% credible intervals -23.6 to -6.7 and -14.4 to -5.5).
- No block reached 80% probability of exceeding the 1.0-point pain MCID, and the authors found no preferred technique and unknown effects on graft function.
- This is a narrative discourse rather than a trial, reviewing debates on radiofrequency ablation of the genicular nerves for chronic knee osteoarthritis pain.
- It addresses six controversies: prognostic blocks, final cannula placement, which nerves to target, ultrasound versus fluoroscopy, pulsed radiofrequency, and use after knee arthroplasty.
- The abstract notes earlier studies reporting pain relief lasting up to 12 months, while recent randomized trials have questioned RFA efficacy.
- The authors attribute conflicting results partly to heterogeneity in patient selection and technical protocols, and aim to guide clinicians and prompt further research.
- This narrative practical review synthesizes indirect pharmacological and adjacent procedural evidence, with no dedicated comparative trial of local anesthetics within RFA.
- It suggests lidocaine 1% as a default for skin and track anesthesia, and avoiding lidocaine 2% near the target nerve where stimulation testing is done, based on mechanistic reasoning.
- Across five randomized trials outside interventional pain settings, premixing lidocaine and bupivacaine showed no onset advantage over bupivacaine alone and sometimes shortened duration.
- The authors conclude these considerations are provisional and call for prospective studies, and they provide an allergy substitution pathway centered on formal allergist evaluation.
- This overview reviews health economic principles and published full and partial economic evaluations of intrathecal drug delivery (ITDD) systems across cancer pain, chronic non-cancer pain, and spasticity.
- ITDD is compared with conventional management strategies, and the analyses span varying perspectives and healthcare settings.
- Most analyses suggest ITDD is cost-effective, particularly for cancer-related pain and spasticity, though the authors caution that findings rest on heterogeneous methods and often small or uncontrolled effectiveness data.
- Evidence for chronic non-cancer pain is sparse and inconsistent, and the authors call for comparative effectiveness research and long-term economic modeling.
- This narrative review draws on PubMed, Google Scholar, reference lists, and intrathecal pump device manuals to cover perioperative, obstetric, and ICU care of patients with implanted intrathecal drug delivery systems.
- It is organized into five sections: intrathecal pharmacology, implantation considerations, perioperative care, neuraxial anesthesia, and device-related safety concerns.
- Where evidence is limited, the authors supplement the literature with expert opinion, so some recommendations rest on consensus rather than data.
- The authors highlight intrathecal medications, their behavior under MRI, and precautions before any neuraxial access in these patients.
- This is a historical commentary, not a primary study, tracing neuraxial therapeutics for pain over roughly the past 50 years.
- It covers the advances leading to current neuraxially targeted therapies and considers where this line of development may lead.
- The abstract reports no quantitative results, sample sizes, or comparative outcomes, so it offers a narrative overview rather than evidence of effect.
- This practical guide synthesizes evidence, consensus recommendations, and international clinical experience on intrathecal drug delivery for refractory pain.
- It covers preimplant evaluation, trialing, pump and catheter selection, perioperative care, early troubleshooting, long-term maintenance, and complication surveillance.
- It reviews intrathecal opioids, local anesthetics, ziconotide, clonidine, and baclofen, with attention to indication-specific dosing and safety, but reports no pooled quantitative results.
- It frames outcomes beyond pain intensity, including function, quality of life, and reduced systemic medication use, and addresses cancer and non-cancer populations separately.
- This narrative review searched five databases and screened studies with three reviewers, then synthesized them descriptively due to heterogeneity.
- It examines intrathecal drug delivery systems for less common refractory pain, including spinal cord injury pain, transverse myelitis, diabetic neuropathy, postherpetic neuralgia and craniofacial pain.
- The authors found the evidence rests mainly on observational studies and small trials, with possible meaningful relief in selected patients but variable magnitude and durability of response.
- They conclude the evidence is limited, that selective clinical use may contribute to this gap, and that future research is needed to define its role.
- Systematic review and meta-analysis of 10 randomized trials of adults undergoing spine surgery, with 655 patients in the 24-hour pain analysis.
- Perioperative intravenous lidocaine infusion was compared with placebo or standard care.
- Lidocaine reduced 24-hour pain (MD -0.83; 95% CI -1.36 to -0.30; p=0.002) and opioid consumption (MD -11.64 mg IV morphine equivalents; 95% CI -16.14 to -7.14), with high heterogeneity (I² 89%).
- A post hoc subgroup analysis found larger pain reduction after instrumented fusion or complex surgery (MD -1.23) than after decompression (MD -0.20), which the authors call hypothesis-generating.
- Narrative review of 63 studies, selected from 558 initial hits and limited to the last 3 years, covering regional anaesthesia for breast surgery.
- Reviews paraspinal blocks such as the erector spinae plane, the thoracic paravertebral block, anterolateral chest wall blocks, the interpectoral block and superficial parasternal intercostal plane block.
- No pooled effect estimates are reported; the authors state that all blocks are superior to local infiltration and that the thoracic paravertebral block is the most reliable.
- The authors note that heterogeneous procedures and outcome measures limit direct comparison between blocks, and they advise tailoring the technique to the operation and the patient.
- This PRISMA systematic review pooled 19 studies, including sham-controlled trials, active-comparator trials and cohorts, of genicular nerve block and radiofrequency ablation for knee osteoarthritis.
- Pooled random-effects meta-analysis was used where data were homogeneous, and structured narrative synthesis otherwise.
- RFA was associated with larger and more durable pain relief than GNB, often lasting 6-12 months, though most of the comparison evidence is indirect.
- Both approaches reduced pain with no serious procedure-related adverse events reported, and the authors call for head-to-head trials with standardised protocols and longer follow-up.